Efficacy and Safety of LEO 43204 in Field Treatment of Actinic Keratosis on Balding Scalp Including 12-month Follow-up

Clinical trial NCT02547363 · COMPLETED

Trial details

NCT number: NCT02547363
Sponsor: LEO Pharma
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Actinic Keratosis

Start date: 2015-11-01
Primary completion: 2016-08-17
Enrollment: 373

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.